NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1134186968 MD
Verify on CMS → Daesman Suri, MD
Endocrinology, Diabetes & Metabolism Physician in Hinsdale, Illinois.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 344 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
39%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$593.61
28 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Daesman Suri, MD filed 2,673 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Hinsdale, Illinois, prescribing 39% generic.
- 3K
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1134186968 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1134186968
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 2,673
- BOOK-THIN 309 in Illinois
- PHOTO-ENUM Ravi Sinha · 2006
Daesman Suri, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,673 ≥ 87th percentile 87% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Daesman Suri, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daesman Suri, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,673 1% vs specialty avg
Specialty distribution in Illinois
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Illinois providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1134186968 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/26/2006 |
Hospital and facility affiliations
Facilities where Daesman Suri, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Dupage Medical Group Ltd
Hinsdale, IL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daesman Suri, MD. Source: openpaymentsdata.cms.gov.
Total received
$594
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Illinois IDFPR 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 - they are NOT specific to Daesman Suri, MD. To verify Daesman Suri, MD's current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases
IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Daesman Suri, MD - brand share 50.0%
Endocrinology, Diabetes & Metabolism Physician average
50% brand-name claims vs 39% generic, on 2,673 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,673
Total Claims
$1.4M
Total Drug Cost
344
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,994
- Total Day Supply
- 208,582
- Brand vs Generic
- 50% brand / 39% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $19K
Patient Demographics
- Average Patient Age
- 72.2 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 29, 65-74: 178, 75-84: 114, 85+: 23
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daesman Suri, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
397 claims
- Metformin Hcl 152
Metformin Hcl
152 claims
- Jardiance 133
Jardiance
133 claims
- Metformin Hcl Er 124
Metformin Hcl Er
124 claims
- Synthroid 117
Synthroid
117 claims
- Glimepiride 78
Glimepiride
78 claims
- Novolog Flexpen 71
Novolog Flexpen
71 claims
- Alendronate Sodium 69
Alendronate Sodium
69 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 397 |
| Metformin Hcl | 152 |
| Jardiance Empagliflozin | 133 |
| Metformin Hcl Er Metformin Hcl | 124 |
| Synthroid Levothyroxine Sodium | 117 |
| Glimepiride | 78 |
| Novolog Flexpen Insulin Aspart | 71 |
| Alendronate Sodium | 69 |
| Unithroid Levothyroxine Sodium | 69 |
| Ozempic Semaglutide | 59 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in IL →
All providers in Illinois →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Daesman Suri, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Daesman Suri, MD's 2,673 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Suri, both outside Illinois so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Illinois
Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as Suri.
One of 309 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Illinois, 5 are shown here.
Dr. Maha Abboud
MD FACE
Melrose Park, IL
Dr. Jumana Abdelkarim
MD
Springfield, IL
Dr. Toufic Abdo
MD
Champaign, IL
Dr. Issa Abedmahmoud
MD
Herrin, IL
Dr. Makarem Abulimon
M.D.
Springfield, IL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Daesman Suri, MD's specialty? ▼
Daesman Suri, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Hinsdale, Illinois. Credentials: MD.
How much does Daesman Suri, MD prescribe under Medicare Part D? ▼
In 2023, Daesman Suri, MD wrote 2,673 Medicare Part D claims totaling $1.4M in drug costs for 344 beneficiaries.
Where is Daesman Suri, MD located? ▼
Daesman Suri, MD is located at 908 N ELM ST STE 301, Hinsdale, IL, 60521. Phone: (630) 286-5090.
What is Daesman Suri, MD's NPI number? ▼
Daesman Suri, MD's National Provider Identifier (NPI) is 1134186968, issued on 04/26/2006.
Does Daesman Suri, MD prescribe more brand-name or generic drugs? ▼
Daesman Suri, MD's prescribing is 50% brand-name and 39% generic drugs by claim count, with $1.3M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Daesman Suri, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Daesman Suri, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daesman Suri, MD accept Medicare? ▼
Daesman Suri, MD appears in CMS Medicare data with 2,673 Part D claims and 344 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daesman Suri, MD's credentials? ▼
Daesman Suri, MD's NPI is 1134186968 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.